WO1999040061A2 - Novel dihydroxyhexanoic acid derivatives - Google Patents
Novel dihydroxyhexanoic acid derivatives Download PDFInfo
- Publication number
- WO1999040061A2 WO1999040061A2 PCT/IB1999/000067 IB9900067W WO9940061A2 WO 1999040061 A2 WO1999040061 A2 WO 1999040061A2 IB 9900067 W IB9900067 W IB 9900067W WO 9940061 A2 WO9940061 A2 WO 9940061A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- octyl
- methyl
- amide
- pharmaceutically acceptable
- treating
- Prior art date
Links
- 0 *[C@](C=O)NP Chemical compound *[C@](C=O)NP 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Description
Claims
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9907655-1A BR9907655A (en) | 1998-02-05 | 1999-01-18 | Derivatives of dihydroxyhexanoic acid |
UA2000074534A UA57824C2 (en) | 1998-02-05 | 1999-01-18 | NEW Dihydroxyhexanoic acid derivatives |
IL13733099A IL137330A0 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
NZ505724A NZ505724A (en) | 1998-02-05 | 1999-01-18 | Dihydroxyhexanoic acid derivatives and their pharmaceutical use |
HU0100832A HUP0100832A3 (en) | 1998-02-05 | 1999-01-18 | Quinoxaline and quinoline carboxamide derivatives, their use and the pharmaceutical compositions containing them |
JP2000530493A JP3693916B2 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
EP99900098A EP1051405B1 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
PL99342817A PL342817A1 (en) | 1998-02-05 | 1999-01-18 | Novel derivatives of dihydroxyhexanic acid |
AU17789/99A AU752407B2 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
SK1126-2000A SK11262000A3 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives and pharmaceutical compositon containing the same |
EA200000741A EA003137B1 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
CA002320388A CA2320388C (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
DE69932920T DE69932920T2 (en) | 1998-02-05 | 1999-01-18 | NEW DIHYDROXYHEXANIC ACID DERIVATIVES |
US09/403,218 US6673801B1 (en) | 1998-02-05 | 1999-01-18 | Dihydroxyhexanoic acid derivatives |
IS5562A IS5562A (en) | 1998-02-05 | 2000-07-14 | New dihydroxyhexanoic acid derivatives |
NO20003965A NO20003965D0 (en) | 1998-02-05 | 2000-08-04 | New dihydroxyhexanoic acid derivatives |
HR20000529 HRP20000529B1 (en) | 1998-02-05 | 2000-08-04 | Novel dihydroxyhexanoic acid derivatives |
BG104726A BG104726A (en) | 1998-02-05 | 2000-08-29 | Novel derivatives of the dihydroxyhexanoic acid |
HK01105717A HK1034969A1 (en) | 1998-02-05 | 2001-08-15 | Dihydroxyhexanoic acid derivatives. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7380198P | 1998-02-05 | 1998-02-05 | |
US60/073,801 | 1998-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999040061A2 true WO1999040061A2 (en) | 1999-08-12 |
WO1999040061A3 WO1999040061A3 (en) | 1999-10-21 |
Family
ID=22115885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/000067 WO1999040061A2 (en) | 1998-02-05 | 1999-01-18 | Novel dihydroxyhexanoic acid derivatives |
Country Status (37)
Country | Link |
---|---|
EP (1) | EP1051405B1 (en) |
JP (1) | JP3693916B2 (en) |
KR (1) | KR100385529B1 (en) |
CN (1) | CN1177834C (en) |
AP (1) | AP992A (en) |
AR (1) | AR016175A1 (en) |
AT (1) | ATE337307T1 (en) |
AU (1) | AU752407B2 (en) |
BG (1) | BG104726A (en) |
BR (1) | BR9907655A (en) |
CA (1) | CA2320388C (en) |
DE (1) | DE69932920T2 (en) |
DZ (1) | DZ2717A1 (en) |
EA (1) | EA003137B1 (en) |
ES (1) | ES2268847T3 (en) |
GT (1) | GT199900011A (en) |
HK (1) | HK1034969A1 (en) |
HR (1) | HRP20000529B1 (en) |
HU (1) | HUP0100832A3 (en) |
IL (1) | IL137330A0 (en) |
IS (1) | IS5562A (en) |
MA (1) | MA26603A1 (en) |
MY (1) | MY133125A (en) |
NO (1) | NO20003965D0 (en) |
NZ (1) | NZ505724A (en) |
OA (1) | OA11448A (en) |
PA (1) | PA8467301A1 (en) |
PE (1) | PE20000243A1 (en) |
PL (1) | PL342817A1 (en) |
SK (1) | SK11262000A3 (en) |
TN (1) | TNSN99013A1 (en) |
TR (1) | TR200002248T2 (en) |
TW (1) | TW470744B (en) |
UA (1) | UA57824C2 (en) |
WO (1) | WO1999040061A2 (en) |
YU (1) | YU47100A (en) |
ZA (1) | ZA99873B (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044365A1 (en) * | 1999-01-29 | 2000-08-03 | Millennium Pharmaceuticals, Inc. | Methods for preventing graft rejection and ischemia-reperfusion injury |
WO2001057023A1 (en) * | 2000-02-04 | 2001-08-09 | Pfizer Products Inc. | Heterocyclic amide derivatives |
WO2002009762A2 (en) * | 2000-07-31 | 2002-02-07 | Schering Aktiengesellschaft | Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
WO2003000235A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
WO2003095440A1 (en) * | 2002-05-14 | 2003-11-20 | Pfizer Products Inc. | Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making |
WO2003095439A1 (en) * | 2002-05-14 | 2003-11-20 | Pfizer Products Inc. | Methods for manufacture of dihydro-furan-2-one derivatives |
WO2004014875A1 (en) * | 2002-08-12 | 2004-02-19 | Pfizer Products Inc. | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
WO2004039787A1 (en) * | 2002-10-30 | 2004-05-13 | Pfizer Products Inc. | Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
WO2004039375A1 (en) * | 2002-10-30 | 2004-05-13 | Pfizer Products Inc. | Methods of using ccr1 antagonists as immunomodulatory agents |
US6746856B2 (en) | 2000-08-09 | 2004-06-08 | Pfizer Inc. | Microbial conversion of bicyclic heteroaromatic compounds |
EP1435917A1 (en) * | 2001-10-18 | 2004-07-14 | Schering Aktiengesellschaft | Solid pharmaceutical formulation for a piperazine urea derivative |
AU778108B2 (en) * | 1999-08-20 | 2004-11-18 | Dow Agrosciences Llc | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
EP2111856A2 (en) | 2002-08-12 | 2009-10-28 | Pfizer Products Inc. | Pharmaceutical compositions of semi-ordered drugs and polymers |
EP2275091A1 (en) | 2001-06-22 | 2011-01-19 | Pfizer Products Inc. | Pharmaceutical compositions comprising adsorbates of an amorphous drug |
US7887840B2 (en) * | 2001-06-22 | 2011-02-15 | Bend Research, Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
US9023393B2 (en) | 2003-08-04 | 2015-05-05 | Bend Research, Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
US9486410B2 (en) | 2002-02-01 | 2016-11-08 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923864A (en) * | 1987-12-15 | 1990-05-08 | Pfizer Inc. | Certain heterocyclic-hexanamides useful for treating hypertension |
EP0708085A2 (en) * | 1994-10-19 | 1996-04-24 | Ciba-Geigy Ag | Antiviral ethers of aspartate protease substrate isosteres |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19708106A1 (en) * | 1997-02-28 | 1998-09-03 | Bosch Gmbh Robert | Device and procedure for information about traffic incidents |
-
1999
- 1999-01-18 BR BR9907655-1A patent/BR9907655A/en not_active Application Discontinuation
- 1999-01-18 IL IL13733099A patent/IL137330A0/en unknown
- 1999-01-18 WO PCT/IB1999/000067 patent/WO1999040061A2/en active IP Right Grant
- 1999-01-18 PA PA19998467301A patent/PA8467301A1/en unknown
- 1999-01-18 UA UA2000074534A patent/UA57824C2/en unknown
- 1999-01-18 TR TR2000/02248T patent/TR200002248T2/en unknown
- 1999-01-18 NZ NZ505724A patent/NZ505724A/en unknown
- 1999-01-18 CA CA002320388A patent/CA2320388C/en not_active Expired - Fee Related
- 1999-01-18 EP EP99900098A patent/EP1051405B1/en not_active Expired - Lifetime
- 1999-01-18 DE DE69932920T patent/DE69932920T2/en not_active Expired - Lifetime
- 1999-01-18 SK SK1126-2000A patent/SK11262000A3/en unknown
- 1999-01-18 YU YU47100A patent/YU47100A/en unknown
- 1999-01-18 AT AT99900098T patent/ATE337307T1/en not_active IP Right Cessation
- 1999-01-18 PL PL99342817A patent/PL342817A1/en not_active Application Discontinuation
- 1999-01-18 AU AU17789/99A patent/AU752407B2/en not_active Ceased
- 1999-01-18 JP JP2000530493A patent/JP3693916B2/en not_active Expired - Lifetime
- 1999-01-18 KR KR10-2000-7008561A patent/KR100385529B1/en not_active IP Right Cessation
- 1999-01-18 EA EA200000741A patent/EA003137B1/en not_active IP Right Cessation
- 1999-01-18 CN CNB998027138A patent/CN1177834C/en not_active Expired - Fee Related
- 1999-01-18 ES ES99900098T patent/ES2268847T3/en not_active Expired - Lifetime
- 1999-01-18 HU HU0100832A patent/HUP0100832A3/en unknown
- 1999-01-27 GT GT199900011A patent/GT199900011A/en unknown
- 1999-02-01 PE PE1999000071A patent/PE20000243A1/en not_active Application Discontinuation
- 1999-02-01 TW TW088101505A patent/TW470744B/en not_active IP Right Cessation
- 1999-02-03 MY MYPI99000363A patent/MY133125A/en unknown
- 1999-02-03 MA MA25448A patent/MA26603A1/en unknown
- 1999-02-03 DZ DZ990018A patent/DZ2717A1/en active
- 1999-02-03 AR ARP990100443A patent/AR016175A1/en unknown
- 1999-02-03 TN TNTNSN99013A patent/TNSN99013A1/en unknown
- 1999-02-04 AP APAP/P/1999/001457A patent/AP992A/en active
- 1999-02-04 ZA ZA9900873A patent/ZA99873B/en unknown
-
2000
- 2000-07-14 IS IS5562A patent/IS5562A/en unknown
- 2000-07-28 OA OA1200000214A patent/OA11448A/en unknown
- 2000-08-04 HR HR20000529 patent/HRP20000529B1/en not_active IP Right Cessation
- 2000-08-04 NO NO20003965A patent/NO20003965D0/en not_active Application Discontinuation
- 2000-08-29 BG BG104726A patent/BG104726A/en unknown
-
2001
- 2001-08-15 HK HK01105717A patent/HK1034969A1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923864A (en) * | 1987-12-15 | 1990-05-08 | Pfizer Inc. | Certain heterocyclic-hexanamides useful for treating hypertension |
EP0708085A2 (en) * | 1994-10-19 | 1996-04-24 | Ciba-Geigy Ag | Antiviral ethers of aspartate protease substrate isosteres |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044365A1 (en) * | 1999-01-29 | 2000-08-03 | Millennium Pharmaceuticals, Inc. | Methods for preventing graft rejection and ischemia-reperfusion injury |
AU778108B2 (en) * | 1999-08-20 | 2004-11-18 | Dow Agrosciences Llc | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
US6689886B2 (en) | 2000-02-04 | 2004-02-10 | Pfizer Inc. | Quinoxalinyl carboxylic acid derivatives |
WO2001057023A1 (en) * | 2000-02-04 | 2001-08-09 | Pfizer Products Inc. | Heterocyclic amide derivatives |
EP1498417A1 (en) * | 2000-02-04 | 2005-01-19 | Pfizer Products Inc. | Heterocyclic amide derivatives |
EA005320B1 (en) * | 2000-02-04 | 2005-02-24 | Пфайзер Продактс Инк. | Heterocyclic amide derivatives |
US6548671B2 (en) | 2000-02-04 | 2003-04-15 | Pfizer Inc | Quinoxalinyl amide derivatives |
WO2002009762A3 (en) * | 2000-07-31 | 2003-01-09 | Schering Ag | Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
US6740636B2 (en) | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
WO2002009762A2 (en) * | 2000-07-31 | 2002-02-07 | Schering Aktiengesellschaft | Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
US6746856B2 (en) | 2000-08-09 | 2004-06-08 | Pfizer Inc. | Microbial conversion of bicyclic heteroaromatic compounds |
US8703199B2 (en) | 2001-06-22 | 2014-04-22 | Bend Research, Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
US8389006B2 (en) | 2001-06-22 | 2013-03-05 | Bend Research, Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
US7887840B2 (en) * | 2001-06-22 | 2011-02-15 | Bend Research, Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
EP2275091A1 (en) | 2001-06-22 | 2011-01-19 | Pfizer Products Inc. | Pharmaceutical compositions comprising adsorbates of an amorphous drug |
US9468604B2 (en) | 2001-06-22 | 2016-10-18 | Bend Research, Inc. | Pharmaceutical compositions of dispersions of drug and neutral polymers |
WO2003000235A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
EP1435917A1 (en) * | 2001-10-18 | 2004-07-14 | Schering Aktiengesellschaft | Solid pharmaceutical formulation for a piperazine urea derivative |
US9486410B2 (en) | 2002-02-01 | 2016-11-08 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
US10357455B2 (en) | 2002-02-01 | 2019-07-23 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
WO2003095439A1 (en) * | 2002-05-14 | 2003-11-20 | Pfizer Products Inc. | Methods for manufacture of dihydro-furan-2-one derivatives |
WO2003095440A1 (en) * | 2002-05-14 | 2003-11-20 | Pfizer Products Inc. | Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making |
EP2111856A2 (en) | 2002-08-12 | 2009-10-28 | Pfizer Products Inc. | Pharmaceutical compositions of semi-ordered drugs and polymers |
WO2004014875A1 (en) * | 2002-08-12 | 2004-02-19 | Pfizer Products Inc. | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
WO2004039375A1 (en) * | 2002-10-30 | 2004-05-13 | Pfizer Products Inc. | Methods of using ccr1 antagonists as immunomodulatory agents |
WO2004039787A1 (en) * | 2002-10-30 | 2004-05-13 | Pfizer Products Inc. | Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents |
US9023393B2 (en) | 2003-08-04 | 2015-05-05 | Bend Research, Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
USRE47033E1 (en) | 2003-08-04 | 2018-09-11 | Bend Research, Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1051405B1 (en) | Novel dihydroxyhexanoic acid derivatives | |
EP0966443B1 (en) | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor | |
JP2718595B2 (en) | Quinoxalines and their production | |
US6673801B1 (en) | Dihydroxyhexanoic acid derivatives | |
NZ523610A (en) | A method of treating inflammatory conditions in a non-human mammal comprising administration of dihydroxyhexanoic acid derivatives | |
MXPA00007690A (en) | Novel dihydroxyhexanoic acid derivatives | |
CZ20002760A3 (en) | Novel derivatives of dihydroxyhexanoic acid and pharmaceutical preparation in which they are comprised | |
US6858744B2 (en) | Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making | |
AU2003250450A1 (en) | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide | |
US20040049057A1 (en) | Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture | |
CZ9902904A3 (en) | Derivatives of heteroarylhexanoic acid amides, pharmaceutical compositions based thereon and treatment or prevention methods | |
KR20050046005A (en) | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide | |
WO2004039792A1 (en) | Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-471/00 Country of ref document: YU Ref document number: 99802713.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09403218 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 505724 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 17789/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 137330 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999900098 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11262000 Country of ref document: SK Ref document number: PV2000-2760 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000/02248 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200000694 Country of ref document: VN |
|
ENP | Entry into the national phase |
Ref document number: 2320388 Country of ref document: CA Ref document number: 2320388 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20000529A Country of ref document: HR Ref document number: 1020007008561 Country of ref document: KR Ref document number: PA/a/2000/007690 Country of ref document: MX Ref document number: 200000741 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 1999900098 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007008561 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: PV2000-2760 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 17789/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020007008561 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2000-2760 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999900098 Country of ref document: EP |